JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • February 12th, 2020 • CGI Cellerate RX, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • February 1st, 2019 • CGI Cellerate RX, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
SUBSCRIPTION AGREEMENTSubscription Agreement • October 18th, 2019 • CGI Cellerate RX, LLC • Orthopedic, prosthetic & surgical appliances & supplies • Texas
The undersigned understands that Sanara MedTech Inc., a Texas corporation (the “Company”), is offering to sell shares of its Common Stock, par value $0.001 per share, in a private placement without registration under the Securities Act of 1933, as amended (the “Securities Act”), or any securities law of any state of the United States, only to “accredited investors” (as defined in Rule 501 of Regulation D under the Securities Act). This subscription agreement (this “Subscription Agreement”) is intended to set forth certain representations, covenants and agreements of the undersigned and the Company with respect to such offer and sale.
